Skip to main content

An official website of the United States government

You have 2 new alerts

NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research

General Information

  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Apr 16, 2024 03:53 pm EDT
  • Original Response Date: May 17, 2024 05:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Jun 01, 2024
  • Initiative:

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
    • 541519 - Other Computer Related Services
  • Place of Performance:

Description

This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ)
nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR
INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for
Cancer Research (FNLCR).


The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center
(FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate
scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and
AIDS. FNLCR is a multi]program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed)
for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which
provides Operations and Technical Support (OTS) for the FNLCR.

The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any
information provided as a result of this Special Notice as no information is being requested. Please be advised that
any submissions provided, despite that no information is requested, become Government property and will not
be returned, nor will there be any ensuing discussions or debriefings.

Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form
a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced
herein for additional information pertaining to business opportunities with the FNLCR, if any.


Description of Work:
A portal environment is needed so that the CESDEP project, goals, offerings, limited clinical data and samples are
made available to the public for browsing, viewing, requesting for use as well as investigating. Key to this project
is enabling an efficient and effective workflow for data visualization and sample request. Secondly, development
of an environment where data exploration and visualization leads to hypothesis generation, which in turn leads
to sample selection is desired.

Objectives Include:
• Develop a public portal that includes a landing page, that advertises the CESDEP initiative in a modern,
professional style.
• Portal functionality will include providing access to the CESDEP biospecimen inventory or a copy of it, for
browsing and filtering based on clinical or assay result data for specimen request purposes through an interface
to either be developed or integrated.
• Portal integrates application or develops capability to find correlations in the data, and drive hypothesis
generation by enabling data visualization.
• Host the CESDEP Portal and all data in a secure environment.

Leidos Biomedical Research, Inc. Point of Contact for a copy of Solicitation/RFP No: S24‐038:
Liam King at Liam.King@nih.gov
For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations

Contact Information

Contracting Office Address

  • OFFICE OF ACQUISITIONS 31Center Dr. 11A35P
  • Bethesda , MD 20892
  • USA

Primary Point of Contact

Secondary Point of Contact





History

  • Jun 01, 2024 11:55 pm EDTSpecial Notice (Original)